Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · IEX Real-Time Price · USD
3.690
-0.055 (-1.47%)
Jul 2, 2024, 2:13 PM EDT - Market closed

CELZ Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 2007
Net Income
-5.29-10.1419.21-36.33-8.48
Upgrade
Depreciation & Amortization
0.090.090.090.070.03
Upgrade
Share-Based Compensation
0.040.070.60.170
Upgrade
Other Operating Activities
-2.872.19-22.1235.657.24
Upgrade
Operating Cash Flow
-8.03-7.8-2.22-0.43-1.21
Upgrade
Change in Investments
3.55-10.08000
Upgrade
Other Investing Activities
-0.1---0.25-
Upgrade
Investing Cash Flow
3.45-10.080-0.250
Upgrade
Share Issuance / Repurchase
-0.2715.4714.7600
Upgrade
Debt Issued / Paid
00-2.070.691
Upgrade
Other Financing Activities
--0.16--
Upgrade
Financing Cash Flow
-0.2715.4712.840.691
Upgrade
Net Cash Flow
-4.85-2.410.630.01-0.22
Upgrade
Free Cash Flow
-8.03-7.8-2.22-0.43-1.21
Upgrade
Free Cash Flow Margin
-89198.72%-8800.19%-2524.99%-264.17%-732.99%
Upgrade
Free Cash Flow Per Share
-5.70-7.13-8.51-7.50-586.42
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).